Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer

Prostate

Volumn 29, Issue SUPPL. 7, 1996, Pages 17-24

  Young, Charles Y F ^a   Seay, Thomas ^a   Hogen, Kristine ^a   Charlesworth, M Cristine ^a   Roche, Patrick C ^a   Klee, George G ^a   Tindall, Donald J ^a  

^a MAYO CLINIC   (United States)

Author keywords

hK2; marker; prostate cancer; PSA

Indexed keywords

KALLIKREIN; DIAGNOSTIC AGENT; MESSENGER RNA; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN;

ANTIBODY SPECIFICITY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METASTASIS; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE TUMOR; REVIEW; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; MALE; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0030339751     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(1996)7+<17::AID-PROS2>3.0.CO;2-G     Document Type: Conference Paper

References (41)

1. Andriole GL, Catalona WJ: Prostate carcinoma. Annu Rev Med 45:351-359, 1994.
2. Bostwick D: Prostate-specific antigen, current role in diagnostic pathology of prostate cancer. Am J Clin Pathol 102 (suppl. 1):531-537, 1994.
3. Keetch DW, Catalona MJ, Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151:1571-1574, 1994.
4. Partin AW, Oesterling JE: The clinical usefulness of prostate-specific antigen update 1994. J Urol 152:1358-1368, 1994.
5. Scardino PT: Problem of prostate cancer. J Urol 152: 1677-1678, 1994.
6. Takayama TK, Vessella RL, Lange PH: Newer applications of serum prostate-specific antigen in the management of prostate cancer. Semin Oncol 21:542-553, 1994.
7. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
8. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Caplen DE, Yuan JJ, Petros JA, Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156-1161, 1991.
9. Littrup PJ: Prostate cancer screening: Appropriate choice? Cancer 74:2016-2022, 1994.
10. Clement JA: The glandular kallikrein family of enzymes: Tissue-specific expression and hormonal regulation. Endocr Rev 10:393-419, 1990.
11. Carbini LA, Scicli GA, Carretero OA: The molecular biology of the kallikrein-kinin system. IV. The human kallikrein gene family and kallikrein substrate. J Hypertens 11:893-898, 1993.
12. Berg T, Bradshaw RA, Carretero OA, Chao J, Chao L, Clements JA, Fahnestock M, Fritz H, Gauthier F, MacDonalds RJ, Margolius HS, Morris BJ, Richards RI, Scicli AG: A common nomenclature for members of the tissue (glandular) kallikrein gene families. Agents Actions Suppl. 38:19-25, 1992.
13. Sutherland GR, Baker E, Hyland VJ, Callen DF, Close JA, Tregear GW, Evans BA, Richards RI: Human prostate-specific antigen (PSA) is a member of the glandular kallikrein gene family at 19 q 13. Cytogenet Cell Genet 48:205-207, 1988.
14. Young CYF, Andrews PE, Montgomery BT, Tindall DJ: Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 31: 818-824, 1992.
15. Young CYF, Montgomery BT, Andrews PE, Qui S, Bilhartz DL, Tindall DJ: Hormonal regulation of prostate-specific antigen mRNA in a human prostatic adenocarcinoma cell line LNCaP. Cancer Res 51:3748-3752, 1991.
16. Qui S, Young CYF, Bilhartz DL, Prescott JL, Farrow GM, He WW, Tindall DJ: In situ hybridization of prostate-specific antigen mRNA in human prostate. J Urol 144:1550-1556, 1990.
17. Hara M, Koyangi Y, Inou T, Fukuyama T: Some physicochemical characteristics of gamma-seminoprotein, an antigenic component for human seminal plasma. Jpn J Legal Med 25:322-324, 1991.
18. Wang MC, Valezula LA, Murphy GP, Chu TM: Purification of a human prostate-specific antigen. Invest Urol 17:159-163, 1979.
19. Watt KWK, Lee PJ, M'TimKulu T, Chan WP, Loor R: Human prostate-specific antigen: Structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 83:3166-3170, 1986.
20. Wang MC, Papsidero LD, Kuriyama M, Valenzula LA, Murphy GP, Chu TM: Prostate antigen: A new potential marker for prostatic cancer. Prostate 2:89-96, 1981.
21. Lundwall A, Lilja H: Molecular cloning of human prostate specific antigen cDNA. FEBS Lett 214:317-322, 1987.
22. Lilja H: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76:1899-1903, 1985.
23. Lee C, Keefer M, Zhao ZW, Kroes R, Bey L, Lui K, Sansibar J: Demonstration of the role of the prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis. J Androl 10:432-438, 1989.
24. Killian CS, Corral DA, Kawinski E, Constantine RI: Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 192:940-947, 1993.
25. Lilja H: Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to α1-antichymotrypsin. Urol Clin North Am 20:681-686, 1993.
26. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Osterling JE: Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era. Urology 45:729-744, 1995.
27. Schedlich LJ, Bennetts BH, Morris BJ: Primary structure of human glandular kallikrein gene. DNA 6:429-437, 1987.
28. Deperthes D, Chapdelaine P, Tremblay RR, Brunet C, Berton J, Hebert J, Lazure C, Dube JY: Isolation of prostatic kallikrein HK2, also known as HGK-1, in human seminal plasma. Biochim Biophys Acta 1245:311-316, 1995.
29. Murtha P, Tindall DJ, Young CYF: Androgen induction of a human prostate-specific kallikrein hKLK2: Characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 32: 6459-6484, 1993.
30. Young CYF, Andrews PE, Tindall DJ: Expression and androgenic regulation of human prostate-specific kallikreins. J Androl 16:97-99, 1995.
31. Hsieh J-T, Wu H-C, Cleave ME, von Eschenbach AC, Chung LWK: Automne regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline. Cancer Res 53:2852-2857, 1993.
32. Saedi MS, Cass MMJ, Goel AS, Grauer L, Okaneya T, Young CYF, Tindall DJ: Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol Cell Endocrinol 109: 237-241, 1995.
33. Grauer LS, Charlesworth C, Saedi MS, Finlay JA, Liu R-S, Kuus-Reichel K, Young CYF, Tindall DJ: Identification of human glandular kallikrein hK2 from LNCaP cells. J Androl 17:353-359, 1996.
34. Prestigiacomo AF, Stamey TA: A comparison of 4 ultrasensitive prostate-specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol 152:1515-1519, 1994.
35. DeAntoni EP, Crawford ED: Pretreatment of metastatic disease. Prostate cancer in the older male. Cancer 74: 2182-2187, 1994.
36. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SF, Gomella LG: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52:6110-6112, 1992.
37. Bautista NC, Cohen S, Anders KH: Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review. Am J Clin Pathol 102:102-108, 1994.
38. Maehara Y, Yamamoto M, Oda S, Baba H, Kusumoto T, Ohno S, Ichiyoshi Y, Sugimachi K: Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer. Br J Cancer 73:83-87, 1996.
39. Katz AE, Olsson CA, Raffo AJ, Coma C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson M, Buttyan R: Molecular staging of prostate cancer with the use of an enhanced reverse-transcriptase-PCR assay. Urology 43:765-775, 1994.
40. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, Fujihiro S, Kawamura T, Komeda H, Horie M, Kaji H, Shimokawa K, Tanaka T, Kawada Y: Detection of micrometastatic prostate cancer cells in lymph nodes by reverse-transcriptase polymerase chain reaction. Cancer Res 53:5350-5354, 1993.
41. Wood DP, Banks ER, Humphreys S, McRoberts JW, Randnekar VM: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74:2533-2540, 1994.